Pharmacology Core
药理学核心
基本信息
- 批准号:8326902
- 负责人:
- 金额:$ 22.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-08 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AlgorithmsAnalytical ChemistryAnimal ModelAnimalsAnti-Retroviral AgentsBiologicalBiological AssayBiological ModelsCell Culture TechniquesCellsClinicalClinical PharmacologyClinical TrialsClinical Trials DesignDataDevelopmentDoseDrug ExposureDrug KineticsFrequenciesHIVHIV InfectionsHIV-1HumanIndustryInfectionLeadLeadershipLogisticsMarketingModelingMonkeysMusNorth CarolinaOutcomePharmaceutical PreparationsPharmacologyPlasmaPlasma CellsProductionResearch ContractsResearch DesignResearch PersonnelResourcesRoleSamplingScreening procedureTechniquesTestingTherapeuticTherapeutic StudiesTissuesToxic effectToxicologyUniversitiesValidationViralbasecollaboratorydesigndrug developmentexperienceindexingmouse modelnonhuman primatepharmacodynamic modelpre-clinicalpreclinical studyscale upsimulationsmall moleculesmall molecule librariessuccess
项目摘要
The role of Preclinical and Clinical Pharmacology is to maximize the likelihood of success of an identified
candidate, or to quickly remove a likely unsuccessful candidate from progressing into further testing. The
primary objective of the Pharmacology Core (Core B) is to provide the investigators of the Martin Deianey
Collaboratory to Eradicate HlV-1 Infection with the pharmacologic expertise to study therapeutic strategies
that reduce the latent viral pool and animal model systems, and to evaluate the pharmacologic basis of viral
persistence in humans. The Pharmacology Core will coordinate access to chemical libraries, assist with lead
candidate production scale-up, coordinate animal toxicology studies, analyze biological matrices for drug
concentrations (both antiretroviral and induction/eradication compounds), provide pharmacokinetic/
pharmacodynamic (PK/PD) modeling for optimal dose and dose frequency selection, and perform trial
simulation to optimize design and sampling strategies. This Core will participate in all aspects of drug
development for identifying and progressing lead induction/eradication candidates. The Core leadership
team (Drs. Kashuba and Tan) has over 20 years combined experience in preclinical and clinical
pharmacology, analytical chemistry, and Core management, and are well-suited to support the projects in
the Collaboratory. This results in a Core which combines academic and industry resources to synergize
strengths.
临床前和临床药理学的作用是最大限度地提高已识别药物的成功可能性。
候选人,或快速移除可能不成功的候选人,使其无法进入进一步的测试。的
药理学核心(核心B)的主要目的是为Martin Deianey的研究者提供
利用药理学专业知识研究治疗策略的根除HlV-1感染合作实验室
减少潜伏病毒库和动物模型系统,并评估病毒的药理学基础,
人类的持久性。药理学核心将协调对化学图书馆的访问,
候选产品生产规模扩大,协调动物毒理学研究,分析药物的生物基质
浓度(抗逆转录病毒和诱导/根除化合物),提供药代动力学/
用于最佳剂量和给药频率选择的药效学(PK/PD)建模,并进行试验
模拟以优化设计和采样策略。该核心将参与药物的各个方面
开发用于确定和推进铅诱导/根除候选药物的方法。核心领导
Kashuba博士和Tan博士的团队在临床前和临床方面拥有超过20年的综合经验
药理学、分析化学和核心管理,非常适合支持以下项目:
合作实验室。这就产生了一个核心,它结合了学术和行业资源,
长处.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Angela D Kashuba其他文献
Angela D Kashuba的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Angela D Kashuba', 18)}}的其他基金
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence
量化抗逆转录病毒依从性的新型质谱成像方法
- 批准号:
9040663 - 财政年份:2016
- 资助金额:
$ 22.61万 - 项目类别:
Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence
量化抗逆转录病毒依从性的新型质谱成像方法
- 批准号:
10260722 - 财政年份:2016
- 资助金额:
$ 22.61万 - 项目类别:
Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs
HIV组织储库中药物生物分布的多物种机制
- 批准号:
9226028 - 财政年份:2014
- 资助金额:
$ 22.61万 - 项目类别:
Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs
HIV组织储库中药物生物分布的多物种机制
- 批准号:
9003024 - 财政年份:2014
- 资助金额:
$ 22.61万 - 项目类别:
Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs
HIV组织储库中药物生物分布的多物种机制
- 批准号:
8706563 - 财政年份:2014
- 资助金额:
$ 22.61万 - 项目类别:
Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal Tissues
预防女性艾滋病毒感染:针对粘膜组织的抗逆转录病毒药物
- 批准号:
8493986 - 财政年份:2011
- 资助金额:
$ 22.61万 - 项目类别:
Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal Tissues
预防女性艾滋病毒感染:针对粘膜组织的抗逆转录病毒药物
- 批准号:
8284294 - 财政年份:2011
- 资助金额:
$ 22.61万 - 项目类别:
UPLC-MS/MS to Support Preclinical and Clinical Antiretroviral Pharmacology Studie
UPLC-MS/MS 支持临床前和临床抗逆转录病毒药理学研究
- 批准号:
8051351 - 财政年份:2011
- 资助金额:
$ 22.61万 - 项目类别:
相似海外基金
Aquatic Analytical Chemistry
水生分析化学
- 批准号:
CRC-2018-00279 - 财政年份:2022
- 资助金额:
$ 22.61万 - 项目类别:
Canada Research Chairs
Spatially Resolved Analytical Chemistry: Magnetic Resonance and Magnetic Resonance Imaging of Materials and Processes.
空间分辨分析化学:材料和过程的磁共振和磁共振成像。
- 批准号:
RGPIN-2022-04003 - 财政年份:2022
- 资助金额:
$ 22.61万 - 项目类别:
Discovery Grants Program - Individual
Analytical Chemistry of Proteins and Peptides
蛋白质和肽的分析化学
- 批准号:
RGPIN-2020-04677 - 财政年份:2022
- 资助金额:
$ 22.61万 - 项目类别:
Discovery Grants Program - Individual
Spatially Resolved Analytical Chemistry - Magnetic Resonance Imaging of Materials
空间分辨分析化学 - 材料的磁共振成像
- 批准号:
RGPIN-2015-06122 - 财政年份:2021
- 资助金额:
$ 22.61万 - 项目类别:
Discovery Grants Program - Individual
Aquatic Analytical Chemistry
水生分析化学
- 批准号:
CRC-2018-00279 - 财政年份:2021
- 资助金额:
$ 22.61万 - 项目类别:
Canada Research Chairs
Droplet-Based Analytical Chemistry Platforms Using Superhydrophobic and Superamphiphobic Surfaces
使用超疏水和超双疏表面的基于液滴的分析化学平台
- 批准号:
RGPIN-2016-04790 - 财政年份:2021
- 资助金额:
$ 22.61万 - 项目类别:
Discovery Grants Program - Individual
Analytical Chemistry of Proteins and Peptides
蛋白质和肽的分析化学
- 批准号:
RGPIN-2020-04677 - 财政年份:2021
- 资助金额:
$ 22.61万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




